VITAL Ancillary Study Results Cast More Doubt On Cardio Benefit From Omega-3, Vitamin D
Executive Summary
AF events occurred in 469 (3.7%) of subjects receiving EPA and DHA supplements compared to 431 (3.4%) of participants receiving placebos. In vitamin D3 and placebo comparison, AF events occurred in 469 (3.7%) versus 431 (3.4%).
You may also be interested in...
STRENGTH Results May Weaken Chances For Omega-3 Fatty Acid Heart Health Claims
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
Vitamin D Benefits Don’t Extend To Preventing Depression In Older Adults – Study
Vitamin D3 intake didn’t prevent depression among consumers 50 and up, according to results of a five-year study published in the Journal of the American Medical Association. The research was among first studies “statistically powered” to answer long-standing question on vitamin’s benefit on mood.
FDA Holds Line On Omega-3 Claims, But Gives Enforcement Discretion For More
Agency says "some credible evidence" suggests intake of EPA and DHA "may reduce the risk of hypertension by lowering blood pressure, this evidence is inconclusive and highly inconsistent" and does not support actual approval of a qualified health claim.